RESEARCH TRIANGLE PARK, N.C., April 26 /PRNewswire/ -- A new study finds
that 68% of pharmaceutical companies rely on online databases to learn trade
secrets and target competitor activities. Online databases are one of the
most popular tools for collecting competitive intelligence (CI) data,
according to pharmaceutical business intelligence leader Cutting Edge
Information ( http://www.PharmaCompetitiveIntelligence.com ).
In addition to providing competitive intelligence professionals with
critical information, online databases help senior leaders execute functions
from R&D and clinical development to licensing sales and marketing.
"Competitive intelligence work is crucial to a pharmaceutical company's
individual brands, therapeutic areas and overall corporate strategies.
Tactical competitive intelligence collection, which includes scouring internal
and external databases for competitive information, assists the company in
retrieving critical information, which may reveal trade secrets and competitor
activities," said Elio Evangelista, senior analyst at Cutting Edge
Information. "Competitive intelligence teams gain a more comprehensive
understanding of a company's technical infrastructure by analyzing online
databases."
Cutting Edge Information's latest report, "Pharmaceutical Competitive
Intelligence: Building Strategic Advantage," available
at http://www.PharmaCompetitiveIntelligence.com , is a comprehensive study
featuring metrics and case studies from 18 top pharmaceutical and
biotechnology companies. The report profiles competitive intelligence teams
from Novartis, Wyeth, AstraZeneca, Sanofi-Aventis, Pfizer and Eli Lilly.
The study shows that competitive intelligence teams benefit from having
senior leadership in place. Senior leaders have a stronger voice to
communicate CI successes. Regardless of title, though, strong competitive
intelligence leaders are able to communicate their successes and win greater
resources for their teams.
In the study, Cutting Edge Information focuses its research on the
following core areas:
* Detailed, phase-by-phase competitive intelligence team budget and
staffing levels
* Key CI activities and timelines
* The impact of centralized and decentralized organizational structures
* Competitive intelligence's role across the commercialization
organization
* Creating a competitive intelligence culture within the company
To download a free summary of this 129-page report, please
visit http://www.PharmaCompetitiveIntelligence.com . For more information on
"Pharmaceutical Competitive Intelligence: Building Strategic Advantage,"
please call Elio Evangelista at 919-433-0214 or e-mail
elio_evangelista@cuttingedgeinfo.com .
Senior Analyst Elio Evangelista is a research project leader with Cutting
Edge Information. Mr. Evangelista's customized research work in competitive
intelligence, cardiovascular marketing, market research, and key opinion
leader management practices are currently in place at several Fortune 500
companies.
SOURCE Cutting Edge Information
 back to top
Related links:
http://www.cuttingedgeinfo.com
http://www.PharmaCompetitiveIntelligence.com
CONTACT:
Elio Evangelista of Cutting Edge Information,
+1-919-433-0214, or elio_evangelista@cuttingedgeinfo.com
|
